Sergei Makarov

Dr. Sergei Makarov


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2014 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
SMSergei Makarov
Sergei Makarov
AHAttila K. Horváth
Attila K. Horváth
Radu Silaghi-DumitrescuRadu Silaghi-Dumitrescu
Radu Silaghi-Dumitrescu
QGQingyu Gao
Qingyu Gao

13 December 2012 in Journal of Sulfur Chemistry
Verified
Journal Article
Closed access
SMSergei Makarov
Sergei Makarov
Radu Silaghi-DumitrescuRadu Silaghi-Dumitrescu
Radu Silaghi-Dumitrescu
In this paper, the implications of sodium dithionite and of some of its related compounds for the development of chemistry in the twentieth century, as well as their applications in newer fields of chemistry, are described.

21 July 2014 in European Journal of Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
DSDenis S. Salnikov
Denis S. Salnikov
SMSergei Makarov
Sergei Makarov
RERudi van Eldik
Rudi van Eldik
PKPolina N. Kucherenko
Polina N. Kucherenko
GBGerry R. Boss
Gerry R. Boss
We conducted a detailed kinetic study of the reaction of the vitamin B12 analog diaquacobinamide [(H2O)2Cbi(III)] with hydrogen sulfide in water from pH 3 to 11. The reaction proceeds in three steps: (1) the formation of three different complexes between cobinamide and hydrogen sulfide, viz., (HO–)(HS–)Cbi(III), (H2O)(HS–)Cbi(III), and (HS–)2Cbi(III); (2) inner‐sphere electron transfer (ISET) in the two complexes with one coordinated HS– ligand to form the reduced cobinamide complex [(H)S]Cbi(II); and (3) the addition of a second molecule of hydrogen sulfide to the reduced cobinamide. ISET does not proceed in the (HS–)2Cbi(III) complex. The final products of the reaction between cobinamide and hydrogen sulfide were found to be independent of pH, and the main product is a complex of cobinamide(II) with the anion radical SSH2–.

25 October 2002 in J. Chem. Soc., Dalton Trans.
Verified
Journal Article
Closed access
PDF file
SMSergei Makarov
Sergei Makarov
EKEvgeny V. Kudrik
Evgeny V. Kudrik
RERudi van Eldik
Rudi van Eldik
ENEkaterina V. Naidenko
Ekaterina V. Naidenko
Thiourea dioxide was used as a precursor for sulfoxylate, SO2 2−, which is shown to reduce the methyl viologen dication to the fully reduced form, this is the first example of a direct study of the reduction with sulfoxylate; an important advantage of sulfoxylate and its parent compound thiourea dioxide, is their ability to reduce nitrite (the final product being nitrogen) and nitrous oxide in alkaline solutions in the absence of a catalyst.

2 January 2014 in European Journal of Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
DSDenis S. Salnikov
Denis S. Salnikov
PKPolina N. Kucherenko
Polina N. Kucherenko
IDIlia Dereven'kov
Ilia Dereven'kov
SMSergei Makarov
Sergei Makarov
RERudi van Eldik
Rudi van Eldik

1 July 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
JMJoanna Myszkowska
Joanna Myszkowska
IDIlia Dereven'kov
Ilia Dereven'kov
SMSergei Makarov
Sergei Makarov
USUte Spiekerkötter
Ute Spiekerkötter
Luciana HannibalLuciana Hannibal
Luciana Hannibal
Hydrogen sulfide (H2S) is a gasotransmitter and the smallest signaling thiol metabolite with important roles in human health. The turnover of H2S in humans is mainly governed by enzymes of sulfur amino acid metabolism and also by the microbiome. As is the case with other small signaling molecules, disease-promoting effects of H2S largely depend on its concentration and compartmentalization. Genetic defects that impair the biogenesis and catabolism of H2S have been described; however, a gap in knowledge remains concerning physiological steady-state concentrations of H2S and their direct clinical implications. The small size and considerable reactivity of H2S renders its quantification in biological samples an experimental challenge. A compilation of methods currently employed to quantify H2S in biological specimens is provided in this review. Substantial discrepancy exists in the concentrations of H2S determined by different techniques. Available methodologies permit end-point measurement of H2S concentration, yet no definitive protocol exists for the continuous, real-time measurement of H2S produced by its enzymatic sources. We present a summary of available animal models, monogenic diseases that impair H2S metabolism in humans including structure-function relationships of pathogenic mutations, and discuss possible approaches to overcome current limitations of study.